Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial
Philip Quirke(University of Leeds), RJ Stephens(MRC Clinical Trials Unit at UCL), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), David Sebag‐Montefiore(University of Leeds), R. Steele(MRC Clinical Trials Unit at UCL), Audrey R. Holliday(MRC Clinical Trials Unit at UCL), Sahil Khanna(Mayo Clinic), Gareth Griffiths(NIHR Evaluation Trials and Studies Coordinating Centre), John R.T. Monson(Northwell Health)
Cited by 58
Related Papers
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
|Journal of Clinical Oncology|2011|678